Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trialRobin Kate Kelley, Ming‐Huang Chen, Thomas Yau et al.|The Lancet|2023Cited by 1k
An unresectable retroperitoneal malignant fibrous histiocytoma: A case reportPo‐Jen Hsiao, Li‐Yuan Bai|Oncology Letters|2016Cited by 5
Metakaryotic Cancer Stem Cells are Constitutively Resistant to X-Rays and Chemotherapeutic Agents, but Sensitive to Many Common DrugsElena V. Gostjeva, William G. Thilly, Vera V. Koledova et al.|Unknown|2016Cited by 3